Eton Pharmaceuticals (ETON) Return on Capital Employed Growth (3y) (2021 - 2025)
Eton Pharmaceuticals (ETON) Return on Capital Employed Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1,301.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 353.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 480.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1,342.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 2,112.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 626.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1,788.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1,809.00 |
| 10 | Eton Pharmaceuticals | 806.97 Mn | 781.03 Mn | 13.10 Mn | 966.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 966.00 |
| Sep 30, 2025 | 4,395.00 |
| Jun 30, 2025 | 5,859.00 |
| Mar 31, 2025 | 5,381.00 |
| Dec 31, 2024 | 443.00 |
| Sep 30, 2024 | 766.00 |
| Jun 30, 2024 | -911.00 |
| Mar 31, 2024 | 5,375.00 |
| Dec 31, 2023 | 17,224.00 |
| Sep 30, 2023 | 26,851.00 |
| Jun 30, 2023 | 19,342.00 |
| Mar 31, 2023 | 13,581.00 |
| Dec 31, 2022 | 12,831.00 |
| Sep 30, 2022 | 7,800.00 |
| Jun 30, 2022 | 2,442.00 |
| Mar 31, 2022 | 1,306.00 |
| Dec 31, 2021 | 5,825.00 |